UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely China Biologic Products is implementing good security practices.
China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is the only blood plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province in China with a population of 93 million. The company is engaged in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.
This report shows a preliminary security rating for China Biologic Products. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
An organization's security posture (or cybersecurity posture) is the collective security status of ...
Email spoofing is the creation of emails with a forged sender address. Because core email protocols ...
Compare China Biologic Products's security performance with other companies